Distinct chromosomal bias of gene expression signatures in the progression of hepatocellular carcinoma

被引:50
|
作者
Midorikawa, Y
Tsutsumi, S
Nishimura, K
Kamimura, N
Kano, M
Sakamoto, H
Makuuchi, M
Aburatani, H
机构
[1] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Meguro Ku, Tokyo 15389004, Japan
[2] Univ Tokyo, Adv Sci & Technol Res Ctr, Intelligent Cooperat Syst Div, Tokyo 15389004, Japan
[3] Univ Tokyo, Hepato Biliary Pancreat Surg Div, Tokyo 15389004, Japan
关键词
D O I
10.1158/0008-5472.CAN-04-1275
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To identify the chromosomal aberrations associated with the progression of liver cancer, we applied expression imbalance map analysis to gene expression data from 31 hepatocellular carcinomas and 19 noncancerous tissues. Expression imbalance map analysis, which detects mRNA expression imbalance correlated with chromosomal regions, showed that expression gains of 1q21-23 (74%), 8q13-21 (48%), 12q23-24 (41%), 17q12-21(48%), 17q25 (25%), and 20q11 (22%) and losses of 4q13 (48%), 8p12-21 (32%), 13q14 (32%), and 17p13 (29%) were significantly associated with hepatocellular carcinoma. Most regions with altered expression identified by expression imbalance map were also identified in previous reports using comparative genomic hybridization. We demonstrated chromosomal copy number gain in 1q21-23 and loss in 17p13 by genomic quantitative PCR, suggesting that gene expression profiles reflect chromosomal alterations. Furthermore, expression imbalance map analysis revealed that more poorly differentiated hepatocellular carcinoma contain more chromosomal alterations, which are accumulated in a stepwise manner in the course of hepatocellular carcinoma progression: expression imbalance of 1q, 8p, 8q, and 17p occur as early events in hepatocarcino-genesis, and 12q, 17q25 and 20q occur as later events. In particular, expression gain of 17q12-21 and loss of 4q were seen to accumulate constantly through the dedifferentiation process. Our data suggest that gene expression profiles are subject to chromosomal bias and that expression imbalance map can correlate gene expression to gene loci with high resolution and sensitivity.
引用
收藏
页码:7263 / 7270
页数:8
相关论文
共 50 条
  • [21] Fascin Expression in Progression and Prognosis of Hepatocellular Carcinoma
    Iguchi, Tomohiro
    Aishima, Shinichi
    Umeda, Kenji
    Sanefuji, Kensaku
    Fujita, Nobuhiro
    Sugimachi, Keishi
    Gion, Tomonobu
    Taketomi, Akinobu
    Maehara, Yoshihiko
    Tsuneyoshi, Masazumi
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (07) : 575 - 579
  • [22] Aberrant AFP expression characterizes a subset of hepatocellular carcinoma with distinct gene expression patterns and inferior prognosis
    Chen, Wei
    Peng, Jianjun
    Ye, Dinning
    Dai, Weigang
    Li, Guanghua
    He, Yulong
    JOURNAL OF CANCER, 2020, 11 (02): : 403 - 413
  • [23] Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats
    Perez-Carreon, Julio Isael
    Lopez-Garcia, Cristina
    Fattel-Fazenda, Samia
    Arce-Popoca, Evelia
    Aleman-Lazarini, Leticia
    Hernandez-Garcia, Sergio
    Le Berre, Veronique
    Sokol, Serguei
    Francois, Jean Marie
    Villa-Trevino, Saul
    NEOPLASIA, 2006, 8 (05): : 373 - U18
  • [24] High FANCD2 Gene Expression is associated with Tumor Progression in Hepatocellular Carcinoma
    Komatsu, Hisateru
    Masuda, Takaaki
    Iguchi, Tomohiro
    Sato, Kuniaki
    Hu, Qingjiang
    Hirata, Hidenari
    Ito, Shuhei
    Eguchi, Hidetoshi
    Sugimachi, Keishi
    Eguchi, Hidetoshi
    Doki, Yuichiro
    Mori, Masaki
    Mimori, Koshi
    CANCER SCIENCE, 2018, 109 : 938 - 938
  • [25] Gene expression of microRNAs in hepatocellular carcinoma
    Varnholt, H.
    Scheffler, M.
    Konze, E.
    Dries, V.
    Drebber, U.
    Schirmacher, P.
    Schulze, F.
    Wedemeyer, I.
    Odenthal, M.
    Dienes, H. P.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 379 - 379
  • [26] Prognostic Gene Signatures for Hepatocellular Carcinoma: What Are We Measuring?
    Kenneth K. Tanabe
    Yujin Hoshida
    Annals of Surgical Oncology, 2013, 20 : 3707 - 3708
  • [27] Prognostic Gene Signatures for Hepatocellular Carcinoma: What Are We Measuring?
    Tanabe, Kenneth K.
    Hoshida, Yujin
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (12) : 3707 - 3708
  • [28] Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed Therapy
    Nunez, Kelley G.
    Sandow, Tyler
    Lakey, Meredith A.
    Fort, Daniel
    Cohen, Ari J.
    Thevenot, Paul T.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes
    Tan, Tuan Zea
    Ye, Jieru
    Yee, Chung Vin
    Lim, Diana
    Ngoi, Natalie Yan Li
    Tan, David Shao Peng
    Huang, Ruby Yun-Ju
    EBIOMEDICINE, 2019, 50 : 203 - 210
  • [30] Hepatocellular Carcinoma Displays Distinct DNA Methylation Signatures with Potential as Clinical Predictors
    Hernandez-Vargas, Hector
    Lambert, Marie-Pierre
    Le Calvez-Kelm, Florence
    Gouysse, Geraldine
    McKay-Chopin, Sandrine
    Tavtigian, Sean V.
    Scoazec, Jean-Yves
    Herceg, Zdenko
    PLOS ONE, 2010, 5 (03):